Related Experiment Video
Updated: Oct 1, 2025

Murine Prostate Micro-dissection and Surgical Castration
Published on: May 11, 2016
ETS-related gene (ERG) undermines genome stability in mouse prostate progenitors via Gsk3β dependent Nkx3.1
Marco Lorenzoni1, Dario De Felice1, Giulia Beccaceci1
1Department of Cellular, Computational and Integrative Biology-CIBIO, University of Trento, Trento, Italy.
Abstract:
21q22.2-3 deletion is the most common copy number alteration in prostate cancer (PCa). The genomic rearrangement results in the androgen-dependent de novo expression of ETS-related gene (ERG) in prostate cancer cells, a condition promoting tumor progression to advanced stages of the disease. Interestingly, ERG expression characterizes 5-30% of tumor precursor lesions - High Grade Prostatic Intraepithelial Neoplasia (HGPIN) - where its role remains unclear. Here, by combining organoids technology with Click-chemistry coupled Mass Spectrometry, we demonstrate a prominent role of ERG in remodeling the protein secretome of prostate progenitors. Functionally, by lowering autocrine Wnt-4 signaling, ERG represses canonical Wnt pathway in prostate progenitors, and, in turn, promotes the accumulation of DNA double strand breaks via Gsk3β-dependent degradation of the tumor suppressor Nkx3.1. On the other hand, by shaping extracellular paracrine signals, ERG strengthens the pro-oxidative transcriptional signature of inflammatory macrophages, which we demonstrate to infiltrate pre-malignant ERG positive prostate lesions. These findings highlight previously unrecognized functions of ERG in undermining adult prostate progenitor niche through cell autonomous and non-autonomous mechanisms. Overall, by supporting the survival and proliferation of prostate progenitors in the absence of growth stimuli and promoting the accumulation of DNA damage through destabilization of Nkx3.1, ERG could orchestrate the prelude to neoplastic transformation.
Insights
The ETS-related gene (ERG) promotes prostate cancer progression by altering progenitor cell secretomes. ERG destabilizes tumor suppressors and promotes DNA damage, potentially initiating cancer development.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- 21q22.2-3 deletion is a common alteration in prostate cancer (PCa).
- This deletion leads to ETS-related gene (ERG) expression, promoting PCa progression.
- ERG is present in High Grade Prostatic Intraepithelial Neoplasia (HGPIN), but its role is unclear.
Purpose of the Study:
- To investigate the role of ERG in prostate progenitor cells.
- To understand how ERG influences the tumor microenvironment.
- To elucidate ERG's contribution to early neoplastic transformation.
Main Methods:
- Organoid technology combined with Click-chemistry coupled Mass Spectrometry.
- Analysis of autocrine Wnt-4 signaling and canonical Wnt pathway activity.
- Assessment of DNA double-strand breaks and Nkx3.1 stability.
- Investigation of macrophage infiltration and transcriptional signatures.
Main Results:
- ERG significantly remodels the protein secretome of prostate progenitors.
- ERG represses Wnt-4 signaling, leading to Nkx3.1 degradation and DNA damage.
- ERG enhances pro-oxidative signals in infiltrating inflammatory macrophages.
- ERG promotes survival and proliferation of prostate progenitors without growth stimuli.
Conclusions:
- ERG plays a critical role in undermining the prostate progenitor niche via cell-autonomous and non-autonomous mechanisms.
- ERG destabilizes the tumor suppressor Nkx3.1, promoting DNA damage accumulation.
- ERG contributes to neoplastic transformation by supporting progenitor survival and proliferation, and inducing DNA damage.
Related Concept Videos
In-vitro Mutagenesis
Abnormal Proliferation

